Moringa Oleifera Ameliorates Cardiotoxicity and Improves Antioxidants in Breast Cancer- induced Rats Treated with Doxorubicin: A Preliminary Study.
Keywords:
Antioxidants, Cardiotoxicity, Moringa Oleifera nanoemulsion, Nanoparticles , Tumor markersAbstract
Moringa Oleifera (MO) is a miracle plant of huge medical significance. It could be used to suppress the aggressiveness of various tumors as well as ameliorate the consequences of chemotherapeutic agents. In the present study; 49 albino rats were used to evaluate the effect of MO nanoparticles (MONPs) in DMBA-induced breast cancer rats (BC-induced) treated with doxorubicin (DOX). Cardiotoxicity, antioxidant markers, and protein profile were evaluated. Serum and mammary glands samples were collected for both biochemical and histopathological examinations. Rats were classified into control and BC-induced rats. The last group was further divided into 6 groups to evaluate the synergistic and prophylactic effects of MONPs. There was a significant reduction in the levels of tumor, and cardiotoxicity markers with a significant increase in the antioxidants/oxidants and proteins profile in BC-induced rats treated synergistically or/and prophylactically with MONPs and DOX. In conclusion, the prophylactic use of MONPs and synergistic use of MONPs and DOX induced a magnificent resistance against cardiotoxicity induced by doxorubicin and ameliorated the aggressiveness of breast cancer as well as the oxidative stress induced in rats.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Advanced Veterinary Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles under the following conditions: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0).
Attribution-NonCommercial-NoDerivs
CC BY-NC-ND
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license